Forward Pharma A/S
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Forward Pharma A/S generated cash of -$2,359,000, which is more than the previous year. Cash used in financing activities reached the amount of $3,000 last year. Net change in cash is therefore -$8,317,000.
Cash Flow
| 2012 | -3.49M | -5K | 3.88M |
|---|---|---|---|
| 2013 | -8.37M | 0 | 10.39M |
| 2014 | -9.46M | -191.12M | 237.57M |
| 2015 | -35.12M | 43.03M | 155K |
| 2016 | -34.10M | 41.17M | 114K |
| 2017 | 939.94M | 85.36M | -1.11B |
| 2018 | -14.78M | 3K | -8.12M |
| 2019 | -2.23M | 0 | -799K |
| 2020 | -5.71M | -1K | -283K |
| 2021 | -2.35M | 0 | 3K |
FWP Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 79.08M | 77.59M | 82.54M | 109.55M | 57.89M | 52.26M | 45.34M | 2.95M | 828K | 427K |
Operating activities | ||||||||||
Net income | -1.89M | -6.44M | -4.22M | -8.72M | 917.09M | -33.33M | -37.00M | -19.01M | -15.69M | -22.47M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 1K | 4K | 227K | 109K | 37K | 3K | 4K | 2K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 579K | 458K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 579K | 458K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | -5.80M | -1.25M | 4.2M | 3.93M | 2.08M | 446K | 607K |
Cash generated by operating activities | -2.35M | -5.71M | -2.23M | -14.78M | 939.94M | -34.10M | -35.12M | -9.46M | -8.37M | -3.49M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -191.11M | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | -3K | -31K | -382K | -6K | 0 | -5K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -1K | 0 | 3K | 85.36M | 41.17M | 43.03M | -191.12M | 0 | -5K |
Financing activities | ||||||||||
Common Stock Issued | 3K | 2K | 0 | 1K | 49K | 114K | 155K | 220.71M | 7.95M | 1.86M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 3K | -283K | -799K | -8.12M | -1.11B | 114K | 155K | 237.57M | 10.39M | 3.88M |
Net Change In Cash | -8.31M | 1.48M | -4.94M | -27.01M | 51.65M | 5.62M | 6.92M | 42.39M | 2.12M | 401K |
Cash at end of period | 70.77M | 79.08M | 77.59M | 82.54M | 109.55M | 57.89M | 52.26M | 45.34M | 2.95M | 828K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |